Published in Infect Immun on March 01, 2002
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Res (2008) 1.11
Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways. PLoS One (2012) 1.09
Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunol Res (2008) 0.94
Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro. Infect Immun (2005) 0.94
Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells. Clin Exp Immunol (2005) 0.93
Differences in gamma interferon production induced by listeriolysin O and ivanolysin O result in different levels of protective immunity in mice infected with Listeria monocytogenes and Listeria ivanovii. Infect Immun (2003) 0.88
Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice. Infect Immun (2003) 0.88
Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection. Infect Immun (2009) 0.87
Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000. Microb Cell Fact (2008) 0.86
Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. Bioeng Bugs (2011) 0.82
Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines. Hum Vaccin Immunother (2013) 0.80
Biotechnological applications of Listeria's sophisticated infection strategies. Microb Biotechnol (2008) 0.79
Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice. Clin Exp Immunol (2006) 0.79
Biological effects of listeriolysin O: implications for vaccination. Biomed Res Int (2015) 0.77
Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy. Cancer Immunol Immunother (2010) 0.77
Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cells. BMC Biotechnol (2014) 0.77
Immunization with genetic toxoids of the Arcanobacterium pyogenes cholesterol-dependent cytolysin, pyolysin, protects mice against infection. Infect Immun (2003) 0.77
Evaluation of the safety and adjuvant effect of a detoxified Listeriolysin O mutant on the humoral response to Dengue virus antigens. Clin Exp Immunol (2016) 0.75
Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med (1988) 12.95
Tn916-induced mutations in the hemolysin determinant affecting virulence of Listeria monocytogenes. J Bacteriol (1987) 7.18
Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Hemolysin supports survival but not entry of the intracellular bacterium Listeria monocytogenes. Infect Immun (1988) 4.90
Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids. Infect Immun (1984) 3.98
PURIFICATION OF THE SOLUBLE HEMOLYSINS OF LISTERIA MONOCYTOGENES. J Bacteriol (1964) 3.35
Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell (1997) 3.17
A review of Listeria monocytogenes and listeriosis. Vet J (1997) 2.72
Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O. Mol Microbiol (1990) 2.68
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
Biochemical and Immunological Effects of Listeria monocytogenes Hemolysin. Infect Immun (1970) 2.07
Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun (1989) 1.91
Nucleotide sequence of the listeriolysin gene from a Listeria monocytogenes serotype 1/2a strain. Nucleic Acids Res (1989) 1.72
The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun (1989) 1.63
The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J Bacteriol (1997) 1.40
Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett (2000) 1.39
Induction of cytokine gene expression by listeriolysin O and roles of macrophages and NK cells. Infect Immun (1996) 1.29
Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin. Eur J Biochem (1996) 1.28
Membrane damage and interleukin-1 production in murine macrophages exposed to listeriolysin O. Infect Immun (1993) 1.24
Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes. Mol Microbiol (1998) 1.16
Induction of macrophage interleukin-1 production by Listeria monocytogenes hemolysin. Cell Immunol (1992) 1.12
A role in cell-binding for the C-terminus of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae. FEMS Microbiol Lett (1994) 1.05
Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Biochem Biophys Res Commun (2001) 0.99
Contribution of tryptophan residues to the structural changes in perfringolysin O during interaction with liposomal membranes. J Biochem (1998) 0.96
C-terminal amino acid residues are required for the folding and cholesterol binding property of perfringolysin O, a pore-forming cytolysin. J Biol Chem (1999) 0.94
Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes. Infect Immun (1997) 0.94
Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin O-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin O. Infect Immun (1999) 0.92
Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation. Infect Immun (1996) 0.83
Analysis of anticholesterol antibodies using hydrophobic membranes. J Immunol Methods (1995) 0.78
Childhood neglect is associated with reduced corpus callosum area. Biol Psychiatry (2004) 2.26
High-resolution multi-dimensional NMR spectroscopy of proteins in human cells. Nature (2009) 2.06
Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med (2014) 2.00
Protein structure determination in living cells by in-cell NMR spectroscopy. Nature (2009) 1.71
Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614. Eur J Pharmacol (2004) 1.64
Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol (2010) 1.52
Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol (2013) 1.51
Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol (2011) 1.33
Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation. Infect Immun (2008) 1.30
Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother (2012) 1.24
Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol (2012) 1.18
Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect Immun (2002) 1.12
The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages. Infect Immun (2009) 1.12
A long-term study of sharps injuries among health care workers in Japan. Am J Infect Control (2007) 1.11
In-cell NMR spectroscopy of proteins inside Xenopus laevis oocytes. J Biomol NMR (2006) 1.10
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09
Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J Immunol (2008) 1.09
Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infect Immun (2010) 1.09
Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography. Respirology (2008) 1.04
Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. Antimicrob Agents Chemother (2013) 1.03
Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans. FEMS Immunol Med Microbiol (2006) 1.03
Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice. Blood (2003) 1.03
A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward. Jpn J Infect Dis (2004) 1.03
Signet ring cell carcinoma of the ampulla of vater. A case report. JOP (2009) 1.02
Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood (2012) 1.01
Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect Immun (2002) 1.00
Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability. Infect Immun (2012) 0.99
Clinical characteristics and risk factors of ocular candidiasis. Diagn Microbiol Infect Dis (2012) 0.96
Seeligeriolysin O, a protein toxin of Listeria seeligeri, stimulates macrophage cytokine production via Toll-like receptors in a profile different from that induced by other bacterial ligands. Int Immunol (2005) 0.96
Solution structure of the C-terminal transcriptional activator domain of FixJ from Sinorhizobium meliloti and its recognition of the fixK promoter. Biochemistry (2005) 0.96
Disseminated Nocardia farcinica infection in a patient with myasthenia gravis successfully treated by linezolid: a case report and literature review. J Infect Chemother (2011) 0.95
HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood (2011) 0.95
A novel approach for the sequential backbone assignment of larger proteins: selective intra-HNCA and DQ-HNCA. J Am Chem Soc (2002) 0.94
Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro. Infect Immun (2005) 0.94
Identification of the RecR Toprim domain as the binding site for both RecF and RecO. A role of RecR in RecFOR assembly at double-stranded DNA-single-stranded DNA junctions. J Biol Chem (2006) 0.94
Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med (2007) 0.93
PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin. Int Immunol (2010) 0.93
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection. J Infect Chemother (2002) 0.93
A novel method for the biosynthesis of deuterated proteins with selective protonation at the aromatic rings of Phe, Tyr and Trp. J Biomol NMR (2003) 0.92
Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection. J Immunol (2012) 0.92
Prognosis of cough variant asthma: a retrospective analysis. J Asthma (2006) 0.92
Myristoylation-regulated direct interaction between calcium-bound calmodulin and N-terminal region of pp60v-src. J Mol Biol (2004) 0.90
Association between polyclonal and mixed mycobacterial Mycobacterium avium complex infection and environmental exposure. Ann Am Thorac Soc (2014) 0.90
Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans. J Antimicrob Chemother (2012) 0.90
Outcome of sarcoidosis. Clin Chest Med (2008) 0.90
A non-canonical DNA structure enables homologous recombination in various genetic systems. J Biol Chem (2009) 0.89
Solution structure of a zinc-finger domain that binds to poly-ADP-ribose. Genes Cells (2010) 0.89
Differences in gamma interferon production induced by listeriolysin O and ivanolysin O result in different levels of protective immunity in mice infected with Listeria monocytogenes and Listeria ivanovii. Infect Immun (2003) 0.88
First outbreak of methicillin-resistant Staphylococcus aureus USA300 harboring the Panton-Valentine leukocidin genes among Japanese health care workers and hospitalized patients. Am J Infect Control (2010) 0.88
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. Jpn J Antibiot (2009) 0.88
Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice. Infect Immun (2003) 0.88
Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report. J Infect Chemother (2011) 0.87
Irreversible loss of membrane-binding activity of Listeria-derived cytolysins in non-acidic conditions: a distinct difference from allied cytolysins produced by other Gram-positive bacteria. Microbiology (2007) 0.87
Involvement of reactive oxygen intermediate in the enhanced expression of virulence-associated genes of Listeria monocytogenes inside activated macrophages. Microbiol Immunol (2005) 0.87